Origin-dependent neural cell identities in differentiated human iPSCs in vitro and after transplantation into the mouse brain

Cell Reports

Volumn 8, Issue 6, 2014, Pages 1697-1703

  Hargus, Gunnar ^a,b   Ehrlich, Marc ^a,b   Araúzo Bravo, Marcos J ^a,c,d   Hemmer, Kathrin ^e,f   Hallmann, Anna Lena ^a,b   Reinhardt, Peter ^a   Kim, Kee Pyo ^a   Adachi, Kenjiro ^a   Santourlidis, Simeon ^g   Ghanjati, Foued ^g   Fauser, Mareike ^h   Ossig, Christiana ^h   Storch, Alexander ^h   Kim, Jeong Beom ⁱ   Schwamborn, Jens C ^e,f   Sterneckert, Jared ^a   Schöler, Hans R ^a,j   Kuhlmann, Tanja ^b   Zaehres, Holm ^a  

^a MAX PLANCK INSTITUTE FOR MOLECULAR BIOMEDICINE   (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^c BIODONOSTIA HEALTH RESEARCH INSTITUTE   (Spain)

^d BASQUE FOUNDATION FOR SCIENCE   (Spain)

^e UNIVERSITY OF LUXEMBOURG   (Luxembourg)

^f UNIVERSITY OF MÜNSTER   (Germany)

^g HEINRICH HEINE UNIVERSITY   (Germany)

^h CENTER FOR REGENERATIVE THERAPIES DRESDEN   (Germany)

ⁱ Ulsan National Institute of Science and Technology   (South Korea)

^j INST OF REPRO MED OF THE UNIV   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; GREEN FLUORESCENT PROTEIN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BRAIN CORTEX; CELL DIFFERENTIATION; CELL SURVIVAL; CONTROLLED STUDY; CORPUS STRIATUM; EMBRYO; FETUS; GENE EXPRESSION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MESODERM; MOUSE; NERVE CELL; NEURAL STEM CELL; NEUROECTODERM; NONHUMAN; NUCLEOTIDE SEQUENCE; PLURIPOTENT STEM CELL; SKIN FIBROBLAST; TRANSCRIPTOMICS; ANIMAL; BRAIN; CELL CULTURE; CONFOCAL MICROSCOPY; CYTOLOGY; FETUS BLOOD; FIBROBLAST; GENE EXPRESSION PROFILING; GENETICS; METABOLISM; NONOBESE DIABETIC MOUSE; TRANSPLANTATION;

ANIMALS; ANTIGENS, CD34; BRAIN; CELL DIFFERENTIATION; CELLS, CULTURED; FETAL BLOOD; FETUS; FIBROBLASTS; GENE EXPRESSION PROFILING; GREEN FLUORESCENT PROTEINS; HEMATOPOIETIC STEM CELLS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MESODERM; MICE; MICE, INBRED NOD; MICROSCOPY, CONFOCAL; NEURAL PLATE; NEURAL STEM CELLS;

EID: 84907394370     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2014.08.014     Document Type: Article

References (21)

1. Bock C., Kiskinis E., Verstappen G., Gu H., Boulting G., Smith Z.D., Ziller M., Croft G.F., Amoroso M.W., Oakley D.H., et al. Reference Maps of human ES and iPS cell variation enable high-throughput characterization of pluripotent cell lines. Cell 2011, 144:439-452.
2. Borst J., Hendriks J., Xiao Y. CD27 and CD70 in Tcell and B cell activation. Curr. Opin. Immunol. 2005, 17:275-281.
3. Han J., Jung S., Jang J., Kam T.I., Choi H., Kim B.J., Nah J., Jo D.G., Nakagawa T., Nishimura M., et al. OCIAD2 activates gamma-secretase to enhance amyloid beta production by interacting with nicastrin. Cell. Mol. Life Sci. 2014, 71:2561-2576.
4. Hargus G., Ehrlich M., Hallmann A.L., Kuhlmann T. Human stem cell models of neurodegeneration: a novel approach to study mechanisms of disease development. Acta Neuropathol. 2014, 127:151-173.
5. Irizarry R.A., Bolstad B.M., Collin F., Cope L.M., Hobbs B., Speed T.P. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res. 2003, 31:e15.
6. Kim H.T., Kim I.S., Lee I.S., Lee J.P., Snyder E.Y., Park K.I. Human neurospheres derived from the fetal central nervous system are regionally and temporally specified but are not committed. Exp. Neurol. 2006, 199:222-235.
7. Kim J.B., Greber B., Araúzo-Bravo M.J., Meyer J., Park K.I., Zaehres H., Schöler H.R. Direct reprogramming of human neural stem cells by OCT4. Nature 2009, 461:649-653.
8. Kim K., Doi A., Wen B., Ng K., Zhao R., Cahan P., Kim J., Aryee M.J., Ji H., Ehrlich L.I., et al. Epigenetic memory in induced pluripotent stem cells. Nature 2010, 467:285-290.
9. Kim K., Zhao R., Doi A., Ng K., Unternaehrer J., Cahan P., Huo H., Loh Y.H., Aryee M.J., Lensch M.W., et al. Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells. Nat. Biotechnol. 2011, 29:1117-1119.
10. Lister R., Pelizzola M., Kida Y.S., Hawkins R.D., Nery J.R., Hon G., Antosiewicz-Bourget J., O'Malley R., Castanon R., Klugman S., et al. Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature 2011, 471:68-73.
11. Liu X., Yu X., Zack D.J., Zhu H., Qian J. TiGER: a database for tissue-specific gene expression and regulation. BMC Bioinformatics 2008, 9:271.
12. Luu P.L., Schöler H.R., Araúzo-Bravo M.J. Disclosing the crosstalk among DNA methylation, transcription factors, and histone marks in human pluripotent cells through discovery of DNA methylation motifs. Genome Res. 2013, 23:2013-2029.
13. Mekhoubad S., Bock C., de Boer A.S., Kiskinis E., Meissner A., Eggan K. Erosion of dosage compensation impacts human iPSC disease modeling. Cell Stem Cell 2012, 10:595-609.
14. Nazor K.L., Altun G., Lynch C., Tran H., Harness J.V., Slavin I., Garitaonandia I., Müller F.J., Wang Y.C., Boscolo F.S., et al. Recurrent variations in DNA methylation in human pluripotent stem cells and their differentiated derivatives. Cell Stem Cell 2012, 10:620-634.
15. Petrenko A.G., Ullrich B., Missler M., Krasnoperov V., Rosahl T.W., Südhof T.C. Structure and evolution of neurexophilin. J.Neurosci. 1996, 16:4360-4369.
16. Polo J.M., Liu S., Figueroa M.E., Kulalert W., Eminli S., Tan K.Y., Apostolou E., Stadtfeld M., Li Y., Shioda T., et al. Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells. Nat. Biotechnol. 2010, 28:848-855.
17. Reinhardt P., Glatza M., Hemmer K., Tsytsyura Y., Thiel C.S., Höing S., Moritz S., Parga J.A., Wagner L., Bruder J.M., et al. Derivation and expansion using only small molecules of human neural progenitors for neurodegenerative disease modeling. PLoS ONE 2013, 8:e59252.
18. Reinhardt P., Schmid B., Burbulla L.F., Schöndorf D.C., Wagner L., Glatza M., Höing S., Hargus G., Heck S.A., Dhingra A., et al. Genetic correction of a LRRK2 mutation in human iPSCs links parkinsonian neurodegeneration to ERK-dependent changes in gene expression. Cell Stem Cell 2013, 12:354-367.
19. Sloan J.L., Johnston J.J., Manoli I., Chandler R.J., Krause C., Carrillo-Carrasco N., Chandrasekaran S.D., Sysol J.R., O'Brien K., Hauser N.S., et al. Exome sequencing identifies ACSF3 as a cause of combined malonic and methylmalonic aciduria. Nat. Genet. 2011, 43:883-886. NIH Intramural Sequencing Center Group.
20. Soldner F., Hockemeyer D., Beard C., Gao Q., Bell G.W., Cook E.G., Hargus G., Blak A., Cooper O., Mitalipova M., et al. Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 2009, 136:964-977.
21. Stahl R., Walcher T., De Juan Romero C., Pilz G.A., Cappello S., Irmler M., Sanz-Aquela J.M., Beckers J., Blum R., Borrell V., Götz M. Trnp1 regulates expansion and folding of the mammalian cerebral cortex by control of radial glial fate. Cell 2013, 153:535-549.